Aug 6, 2004
My son has been on meds (Reyataz,Combivnar, Norvair) for 6 weeks and already CD-4 is up from 22 to 230. His viral load was 490,000 and now undetectalbe, YEA!!, however there were some nasty side effects ( yellow skin and eyes, stomach discomfort ((nausea, pain and swelling, making it imposible to eat)), and a low red blood cell count) his doctor, at the Moore Clinic, changed his medication to Kaletra, Viread and Emtriva. What is your take on this comnination. Do you see room for diminished side effects? and what about effeft on CD-4 and VL? Your help has been a blessing Thank you Susan
| Response from Dr. Henry
Kaletra, Viread and Emtriva is also an excellent combination (the Viread and Emtriva can be given as the one pill once a day Truvada just approved by the FDA). Kaletra usually has more GI side effects and lipid elevations than Reyataz/ritonavir. Most patients do well with it--other options are available if Kaletra is not tolerated (just as Lexiva/ritonavir or an NNRTI based regimen such as using Sustiva) depending on the resistance status and other individualized factors. KH
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Sore On Mouth Sign Of Ars
- Tingling Lips Sign Of Seroconversion
- Probability Of Getting HIV From Blowjob From A Prostitute
- Chest Cold After Oral Sex With No Protection Does It Mean I Have HIV
- Itchy Red Spots After Sensual Massage Sign Of HIV AIDS
- Muscle Ache After Unprotected Sex Without Ejaculation Sign Of HIV AIDS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.